Dear John,

Today's Featured Articles

Medicaid Enrollees With Opioid Use Disorder Were More Likely To Receive Medication Treatment Than Commercial Enrollees

Karen Shen et al.

The Quality Of Opioid Use Disorder Treatment In Medicare Is Low And Lags Behind Medicaid

Tami L. Mark et al.

States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24

Stephen Crystal et al.

Secretary Kennedy’s Vaccine Skepticism Is Misplaced: Try Cancer Drugs Instead

Daniel Aaron

More on Cancer Drugs

New Cancer Drug Approvals: Less Than Half Of Important Clinical Trial Uncertainties Reported By The FDA To Clinicians, 2019–22

Avi Cherla et al. (July 2025)

Adopting Weight-Based Dosing With Pharmacy-Level Stewardship Strategies Could Reduce Cancer Drug Spending By Millions

Alex Bryant et al. (July 2023)

Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials

Richard Frank et al. (August 2022)

Community & State is the business segment of UnitedHealthcare that provides health care coverage for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health plans. These state-based health plans meet local needs, while leveraging the national resources of UnitedHealthcare.

Theme Issue Briefing: Insights About The Opioid Crisis

On September 3 Health Affairs held a virtual event where authors discussed their major findings and insights from Health Affairs’ September theme issue on opioids.

Panels included:

• Geographic and Systemic Challenges in the Opioid Crisis
• Expanding Access to Opioid Treatment and Harm Reduction
• Opioid Treatment Coverage, Access, and Quality Across Payers
• Treatment Gaps for Youth and Justice-Involved Individuals